ABSTRACT
4
To test our hypothesis, we used a previously generated transgenic mouse model of NSML-associated
83
HCM. In this model, cardiomyocyte-specific expression of the mutant protein Q510E-SHP2 starting 84 before birth results in neonatal-onset HCM (43). This mouse model recapitulates the aggressive form of 85 HCM found in patients carrying the same SHP2 mutation. Importantly, all our prior findings in the 86 Q510E-SHP2 model are consistent with the HCM phenotype described in other NSML models based on 87 the Y279C and T468M mutations in SHP2 (30, 45) . Because of the severity and early onset of the cardiac 88 phenotype, the Q510E-SHP2 mouse model is ideally suited for proof-of-principle studies. In this 89 investigation, cardiac contractile function early in the course of disease progression was determined in 90 vivo. Subsequently, isolated cardiomyocytes and skinned myofiber preparations from these mouse hearts 91 were used to examine calcium handling and sarcomeric biomechanical properties.
93

MATERIALS AND METHODS
95
Animals. Generation of these transgenic mice and detailed phenotype analyses were previously 96 reported (43). For the current studies, only 4 week-old mice of either gender were used. All protocols 
100
Echocardiography. Echocardiograms were performed under inhalation anesthesia (1.2-1.8% isoflurane, 0.6 L flow of O 2 ) using a Vevo 2100 ultrasound system (Visualsonics, Toronto, Canada). The echocardiographer was blinded to the mouse genotype. M-mode echocardiography was performed using the parasternal short-axis view of the left ventricle (LV). The guidelines of the American Society of Echocardiography were used for measurement of the LV end-diastolic and end-systolic diameters, and septal and posterior wall thickness. Images were captured digitally and 6 consecutive cardiac cycles were measured and averaged for each animal.
Protein analyses. For total protein extracts, flash-frozen mouse ventricles were homogenized in lysis buffer (150 mM NaCl, 10 mM Tris, pH 7.4, 1% Triton X-100, 1x HALT Protease & Phosphatase Inhibitor Cocktail (Sigma-Aldrich, St. Louis, MO). The following antibodies were used for Western blotting: Akt, phospho-Akt (Ser473), glyceraldehyde-3-phosate dehydrogenase (GAPDH), phospholamban (PLB), and phosphoPLB (Ser16/Thr17) from Cell Signaling Technologies, Beverly, MA; sarco/endoplasmic reticulum Ca 2+ ATPase-2 (SERCA), sodium-calcium exchanger (NCX), calsequestrin 2 (CSQ), ryanodine receptor (RyR), and phosphor-ryanodine receptor (pRyR Ser2808) from Abcam, Cambridge, MA; cardiac myosin binding protein C (cMYBP-C, MYBPC3) and -myosin heavy chain (-MHC, MYH1/2/4/6) from Santa Cruz Biotechnology, Santa Cruz, CA; 1C subunit (Ca V 1. 
177
at 95°C for 3 min. The samples were then separated by SDS-PAGE for 2.5 hrs at 12 mA, silver stained to 178 control for loading, and subsequently exposed to X-ray film for visualization.
179
Transmission electron microscopy. Hearts were perfused with phosphate-buffered saline containing 25 180 mM KCl and 5% dextrose, fixed in 2% paraformaldehyde and 2% glutaraldehyde in 0.1 sodium 
195
Cardiac myofiber purification. Equal amounts of ventricular tissue (by weight) from NTG and TG
196
mice were used for extraction of cardiac myofibers as described (22, 44 
216
In short, newborn mice exhibit increased cardiomyocyte cross-sectional areas, heart-to-body weight 217 ratios, interventricular septum thickness, and cardiomyocyte disarray. In adult mice, interstitial fibrosis
218
can be detected and contractile function is depressed.
219
To quantify the degree of cardiac hypertrophy in TG hearts early in the course of disease, we obtained 220 detailed gravimetric data at 4 weeks of age for this study. As shown in Fig. 1 A and B, absolute heart 221 weights as well as the heart-to-body weight ratio were significantly increased both in male and female
222
TGs compared to NTG mice. Since we had noted a small variation in body weight between groups (NTG 223 female 18.55 ± 0.26, TG female 17.93 ± 0.36, NTG male 20.35 ± 0.56, TG male 19.41 ± 0.8 g) and since 224 atrial enlargement could have substantially contributed to the difference in heart-to-body weight ratio, we 225 also calculated the ventricular weight-to-tibia length ratios (Fig. 1C) fractional shortening compared to NTG littermates (Fig. 1, F and G) , indicating hypercontractile function.
239
Next, we confirmed that signaling through Akt is increased in TG mice at this age. Western blotting using 240 ventricular tissue showed a 2.6-fold increase of relative Akt phosphorylation over baseline ( (Fig. 2D ). SR calcium content was assessed by rapid application of 10 mM
253
caffeine following cessation of a 0.5 Hz stimulation train, and was significantly elevated in 254 cardiomyocytes from TG mice (Fig. 2E ).
255
To further investigate the ability of the SR to sequester calcium we monitored the protein expression
256
of SERCA and its regulatory accessory protein PLB. While SERCA protein expression was significantly 257 increased in TG, the expression of PLB was unchanged between TG and NTG hearts (Fig. 3) . Further, the 258 ratio between phospho-PLB and PLB, was unchanged comparing TG and NTG hearts (Fig. 3) . Protein 259 expression of RyR and the phospho-RyR/RyR ratio were unchanged between TG and NTG hearts.
260
Similarly, protein expression of CSQ, Ca V 1.2, and NCX were also not altered by Q51E-SHP2 expression 261 (Fig. 3) .
262
Q510E-SHP2 expression increases sarcomeric contractile function. Next, we considered the 263 possibility of other, calcium-independent effects of Q510E-SHP2 expression that may enhance contractile 264 function. In particular, we focused on the biomechanical characteristics of the contractile apparatus. Using 265 skinned cardiomyocyte preparations from NTG and TG hearts, the force-generating capability was 266 measured at a fixed calcium concentration. Fig. 4 A -D shows representative recordings of shortening and 10 force over time during a series of force clamps followed by slackening. Fig. 4 
275
NTG mice (Q510E-SHP2-10.5 ± 0.9 s -1 versus NTG-8.0 ± 0.7 s -1 p < 0.05) (Fig. 4, G and H) . 
288
For further confirmation, a backphosphorylation assay was used. Sarcomeric proteins from skinned 289 cardiomyocytes were incubated with active PKA in the presence of radiolabeled ATP, and subsequently 290 separated by gel electrophoresis. The degree of radiolabel incorporation in the various sarcomeric proteins 291 did not differ between cardiomyocytes from NTG versus TG hearts (Fig. 5, C and D) .
292
Q510E-SHP2 expression increases the contractile apparatus, but not sarcomeric protein mRNA.
293
Electron microscopy was utilized to examine ultrastructural morphological differences in NTG and TG
294
cardiomyocytes that could explain the functional differences. Representative electron microscopy images 295 prepared from 4 week-old hearts are shown in Fig. 6A . There were no significant differences in sarcomere 296 organization or sarcomere length between the NTG and TG hearts (p = 0.22, Fig. 6B ). However, the 297 relative area per visual field occupied by sarcomeres was significantly increased in TG compared to NTG 298 myocardium (Fig. 6C ). This indicates that more thin and thick filaments per cardiomyocyte width may be 299 available for force generation, which is consistent with the increased power developed by the skinned TG 300 cardiomyocyte preparations.
11
This led to the hypothesis that transcription of sarcomeric proteins may be increased by expression of 302 Q510E-SHP2. To quantify mRNA levels of α-MHC, cTnI, and cMyBP-C, qRT-PCR was used. There
303
were no significant differences in mRNA expression of α-MHC, cTnI, or cMyBP-C when comparing 304 ventricular tissue samples from NTG (n = 5) and TG (n = 4) mice (Fig. 6D) 
348
accelerates relaxation (13), which is consistent with the trend towards decreased  that we observed.
349
Therefore, the increase in SERCA expression in the Q510E-SHP2 model is most likely mediated by Akt.
350
In addition to regulating SERCA expression, Akt has been shown to regulate LTCC activity (2, 19).
351
Similar to the findings of Kim et al. (19) , LTCC expression was unchanged between TG and NTG in our 
359
Independent of all changes in calcium handling, we found that Q510E-SHP2 increases contractile 360 function of skinned cardiac myofibers. Our initial hypothesis had been that the increase in power 
367
Having excluded increased PKA activity as the responsible mechanism, we used electron microscopy 368 to quantify the amount of contractile fibers in the TG myocardium and found that Q510E-SHP2 13 expression increased the contractile machinery. Consistent with this, we previously reported that Q510E-
370
SHP2 increases sarcomeric organization as well as overall protein synthesis in neonatal rat 371 cardiomyocytes (42). Our current data are also consistent with the electron microscopic findings in a 372 different NSML mouse model based on ubiquitous expression of Y279C-SHP2 (30). As sarcomeres are 373 assembled, strict stoichiometry between the different components appears to be preserved (36).
374
Importantly, sarcomeres are dynamic structures with ongoing incorporation and turnover of the 375 contractile proteins via exchange from a free pool (29, 39, 50). As we could not detect any changes in 376 total sarcomeric protein levels, but found increased amounts of myofibers that could be extracted from 377 ventricular tissue, we suspect that Q510E-SHP2 expression leads to alterations in the kinetics of 378 sarcomere assembly. This would be consistent with a recent Xenopus study demonstrating that SHP2
379
regulates formation and polarity of cardiac actin fibers during development (23). On the other hand, it is 380 possible that Q510E-SHP2 expression reduces contractile fiber degradation and turnover. To date, there is 381 no evidence that SHP2 participates in proteasomal pathways, but this remains to be explored.
382
It is possible that isoform switches of various contractile proteins contribute to the increase in power 383 output in transgenic hearts. We previously found that -skeletal actin mRNA was increased in transgenic 384 hearts. Interestingly, expression of this isoform has been shown to be associated with increased 385 contractility compared to hearts primarily expressing -cardiac actin (15). Therefore, this could be
386
another contributing factor enhancing contractility in our NSML model.
387
Understanding the molecular and cellular mechanisms that induce the NSML phenotype is critical for 
